Stay updated on CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Sign up to get notified when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.

Latest updates to the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check12 days agoChange DetectedThe footer’s revision label changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe 403 Forbidden page HTML and related navigation were removed, indicating the page is no longer in an error state and may render the study details.SummaryDifference0.5%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied notice. This indicates the page is no longer accessible and the detailed trial information is no longer visible.SummaryDifference19%

- Check54 days agoChange DetectedThe page footer was updated to include standardized site-wide navigation, policy links, and release notes, reflecting a site-wide maintenance update rather than a change to the study details.SummaryDifference100%

Stay in the know with updates to CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.